Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II.
Stone GW, Reifart NJ, Moussa I, Hoye A, Cox DA, Colombo A, Baim DS, Teirstein PS, Strauss BH, Selmon M, Mintz GS, Katoh O, Mitsudo K, Suzuki T, Tamai H, Grube E, Cannon LA, Kandzari DE, Reisman M, Schwartz RS, Bailey S, Dangas G, Mehran R, Abizaid A, Moses JW, Leon MB, Serruys PW. Stone GW, et al. Among authors: teirstein ps. Circulation. 2005 Oct 18;112(16):2530-7. doi: 10.1161/CIRCULATIONAHA.105.583716. Circulation. 2005. PMID: 16230504 Review. No abstract available.
Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial).
Moses JW, Moussa I, Leon MB, Teirstein PS, Fish RD, Ellis SG, Nawas D, Kluck B, Giorgianni JA, Donohoe D, Kuntz RE. Moses JW, et al. Among authors: teirstein ps. Am J Cardiol. 2002 Aug 1;90(3):243-7. doi: 10.1016/s0002-9149(02)02462-1. Am J Cardiol. 2002. PMID: 12127611 Clinical Trial.
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis.
Prpic R, Teirstein PS, Reilly JP, Moses JW, Tripuraneni P, Lansky AJ, Giorgianni JA, Jani S, Wong SC, Fish RD, Ellis S, Holmes DR, Kereiakas D, Kuntz RE, Leon MB. Prpic R, et al. Among authors: teirstein ps. Circulation. 2002 Oct 29;106(18):2340-5. doi: 10.1161/01.cir.0000036366.62288.74. Circulation. 2002. PMID: 12403664
Pilot trial of oral rapamycin for recalcitrant restenosis.
Brara PS, Moussavian M, Grise MA, Reilly JP, Fernandez M, Schatz RA, Teirstein PS. Brara PS, et al. Among authors: teirstein ps. Circulation. 2003 Apr 8;107(13):1722-4. doi: 10.1161/01.CIR.0000066282.05411.17. Epub 2003 Mar 24. Circulation. 2003. PMID: 12665483 Clinical Trial.
Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trial.
Costantini CO, Lansky AJ, Mintz GS, Shirai K, Teirstein PS, Stone G, Vandertie L, Proctor B, Fahy M, Yeung A, Raizner AE, Waksman R, Leon MB; INHIBIT trial. Costantini CO, et al. Among authors: teirstein ps. Am J Cardiol. 2003 May 15;91(10):1261-5. doi: 10.1016/s0002-9149(03)00280-7. Am J Cardiol. 2003. PMID: 12745117 Clinical Trial. No abstract available.
Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions.
Costantini CO, Lansky AJ, Mintz GS, Shirai K, Dangas G, Mehran R, Fahy M, Slack S, Coral M, Teirstein PS, Waksman R, Stone G, Moses J, Leon MB. Costantini CO, et al. Among authors: teirstein ps. J Am Coll Cardiol. 2003 May 21;41(10):1725-31. doi: 10.1016/s0735-1097(03)00298-5. J Am Coll Cardiol. 2003. PMID: 12767655 Free article. Clinical Trial.
201 results